Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 2Neoplasms 1Lung Neoplasms 1

Interventions

Specimen Handling 655pembrolizumab 608Magnetic Resonance Spectroscopy 561Carboplatin 449Cisplatin 398Cyclophosphamide 396Biopsy 380Nivolumab 325Paclitaxel 323Gemcitabine 317Radiotherapy 298Bevacizumab 248Dexamethasone 223fludarabine 215Docetaxel 202durvalumab 195Oxaliplatin 189venetoclax 186atezolizumab 183Fluorouracil 177Rituximab 176Pemetrexed 173Capecitabine 170Radiation 168Doxorubicin 166Radiosurgery 161Ipilimumab 147Etoposide 142Leucovorin 140Lenalidomide 139

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carbon Monoxide × 90 days × Clear all
NCT06038526 2026-05-20

Evaluation of Canakinumab in High-Risk Former-Smokers

Ohio State University Comprehensive Cancer Center

Phase 2 Active not recruiting
41 enrolled
Thoracic

Lung Neoplasms

NCT03059940 2026-04-15

Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
630 enrolled

Smoking Cessation

NCT05941858 2026-04-02

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled

Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡